| $SMR Class Action Reminder: NuScale Power Investors are Reminded to Contact BFA Law after Company Sued for Securities Fraud Over ENTRA1 Issues |
Globe Newswire |
04/13 |
06:36 |
| Parsons Selected to Lead Design of $409M Roosevelt Bridge Replacement |
Globe Newswire |
04/13 |
06:30 |
| Regeneron and Telix Announce Strategic Radiopharma Collaboration |
Globe Newswire |
04/13 |
06:30 |
| EnviroGold Advances Critical Minerals Supply Opportunities Through Centralized Processing Hub Strategy |
Globe Newswire |
04/13 |
06:30 |
| Telix and Regeneron Announce Strategic Radiopharma Collaboration |
Globe Newswire |
04/13 |
06:30 |
| ORO Labs to Host Orchestrating Procurement for Impact Workshop at The US Summit |
Globe Newswire |
04/13 |
06:22 |
| Crypto.com launches “Level-Up” program to accelerate the world’s transition to cryptocurrency |
Globe Newswire |
04/13 |
06:04 |
| ProSomnus® Receives FDA Class II Clearance for RPMO2 OSA Device |
Globe Newswire |
04/13 |
06:00 |
| BGIN BLOCKCHAIN LIMITED Announces Resolution of Subsidiary’s Hosting Dispute and Full Recovery of Mining Machines |
Globe Newswire |
04/13 |
06:00 |
| Vitaquest Fall 2026 Dietary Supplement Trends Report: Key Insights for Brands and Manufacturers |
Globe Newswire |
04/13 |
06:00 |
| Springboards Launches ‘Flint’ to Break AI’s Habit of Predictable, Boring Answers |
Globe Newswire |
04/13 |
06:00 |
| Over a third of Americans would accept twice as many ads for cheaper streaming |
Globe Newswire |
04/13 |
04:00 |
| Boehringer Ingelheim introduces LENZELTA®: A new vaccine advancing mastitis prevention in dairy cows |
Globe Newswire |
04/13 |
03:51 |
| Facephi Strengthens Its International Expansion with the Opening of a Subsidiary in Canada |
Globe Newswire |
04/13 |
03:20 |
| CallTower Expands Channel Leadership with Two Key Director Appointments |
Globe Newswire |
04/13 |
03:00 |
| TaxTec, Proxymity and Label Launch End-to-End MiKaDiv Solution for Withholding Tax Compliance |
Globe Newswire |
04/13 |
02:53 |
| Baker Hughes Announces Sale of Waygate Technologies to Hexagon |
Globe Newswire |
04/13 |
02:00 |
| Transgene Completes Patient Randomization in Phase 2 Part of Clinical Trial Evaluating TG4050 in the Adjuvant Treatment of Head and Neck Cancer |
Globe Newswire |
04/13 |
02:00 |
| SynOx Therapeutics Announces Positive Topline Results from the Phase 3 TANGENT Study, Supporting Emactuzumab as a Differentiated, Next-generation Treatment for Patients with Tenosynovial Giant Cell Tumor (TGCT) |
Globe Newswire |
04/13 |
02:00 |
| CORRECTION - Israel Tech Week Moves Forward in Miami Amid Ongoing War in Israel |
Globe Newswire |
04/13 |
01:03 |
| WISeSat and Swiss Space Command of the Swiss Armed Forces Complete Pilot Phase and Prepare Next-Generation WISeSat 6U Mission Planned for November 2026 |
Globe Newswire |
04/13 |
01:00 |
| Press Release: Sanofi and Regeneron’s Dupixent approved in the EU as the first targeted medicine to treat young children with chronic spontaneous urticaria |
Globe Newswire |
04/13 |
01:00 |
| Data Published in Nature Communications Highlights Unique Mechanism of Action of Alpibectir in Combination with Ethionamide (AlpE) |
Globe Newswire |
04/13 |
01:00 |
| Dupixent® (dupilumab) Approved in the EU as the First Targeted Medicine to Treat Young Children with Chronic Spontaneous Urticaria (CSU) |
Globe Newswire |
04/13 |
01:00 |
| Strong Technical Services (STS) Announces Acquisition of CinemaNext U.S., Expanding Nationwide Service and Manufacturing Footprint |
Globe Newswire |
04/13 |
00:00 |
